Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera

OBJECTIVE: To evaluate the pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after a single subcutaneous injection in the abdomen of 150 or 300 mg Depo-Provera and compare results to two injections of Depo-SubQ Provera 104 given 3 months apart. DESIGN: Partially randomized, multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Vera, Brache, Vivian, Taylor, Douglas, Lendvay, Anja, Cochón, Leila, Jensen, Jeffrey T., Dorflinger, Laneta J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier for the American Society for Reproductive Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051852/
https://www.ncbi.nlm.nih.gov/pubmed/33485608
http://dx.doi.org/10.1016/j.fertnstert.2020.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051852/
https://www.ncbi.nlm.nih.gov/pubmed/33485608
http://dx.doi.org/10.1016/j.fertnstert.2020.11.002

Ejemplares similares